CASP3 and cervical carcinoma: Here, we demonstrated that TCS treatment was available to reduce cervical cancer cell viability in a time- along with dose-dependent way, thus inhibiting cell proliferation along with promoting cell apoptosis, accompanied with increased caspase-3, PARP and BIM protein levels.